2ATA Soft Sitting HBOT chamber Rejuven S200 Patent Statement

2026-04-17

Recently, DR HUGO has received a significant volume of customer feedback revealing that certain unscrupulous manufacturers in the market are brazenly plagiarizing our patented product—the Rejuven S200 2ATA Soft-Shell Seated Hyperbaric Oxygen Chamber. These parties are selling counterfeit goods while passing them off as authentic products, thereby severely infringing upon our intellectual property rights and posing grave risks to the legitimate interests and safety of our valued customers.

Accordingly, DR HUGO hereby solemnly issues this statement to sternly condemn all acts of infringement and plagiarism, to unequivocally affirm our commitment to protecting our rights, and to call upon our customers to join us in boycotting counterfeit products and safeguarding their own interests.

The Rejuven S200 2ATA Soft-Shell Seated Hyperbaric Oxygen Chamber—a flagship achievement of DR HUGO’s core R&D efforts—embodies years of dedication and substantial investment by our research and development team. From product design, structural optimization, and material selection to breakthroughs in pressure stabilization technology, every stage underwent rigorous testing and iterative refinement. This process ultimately culminated in a major technical innovation within the industry: it is the first soft-shell seated hyperbaric oxygen chamber on the market capable of consistently maintaining an operating pressure of 2 ATA. By overcoming the technical bottleneck that traditionally limited the pressure capabilities of soft-shell chambers, it delivers a more efficient, safer, and more comfortable oxygen therapy experience for users.
The launch of this product not only demonstrates DR HUGO’s technical prowess in the field of hyperbaric oxygen chambers but also fills a significant market gap for 2 ATA soft-shell seated units. Both its core technologies and product design have been granted relevant national patent protection and are strictly safeguarded by law. Rejuven S200_Design Patent Certificate

Based on information and supporting evidence provided through customer feedback, it has come to light that certain manufacturers engaged in plagiarism merely mimic the external design of the Rejuven S200, yet fail to replicate its core technology and quality standards. Customers have reported that counterfeit products sold by one such manufacturer—despite claims to the contrary—can only achieve a maximum pressure of 1.5 ATA. This falls far short of the Rejuven S200's core advantage of maintaining a stable 2 ATA pressure; moreover, these imitations suffer from issues such as pressure instability, poor sealing performance, and significant safety hazards. Not only do these counterfeit products fail to deliver effective oxygen therapy to users, but their substandard technology and inferior materials also pose a serious risk of triggering safety incidents during use, thereby gravely endangering the physical health and property safety of consumers.
Client feedback

DR HUGO hereby explicitly declares that the Rejuven S200 2ATA Soft Seated Hyperbaric Oxygen Chamber is an exclusive patented product of our company. Any manufacturer or individual who, without our authorization, unauthorizedly produces, sells, or counterfeits this product commits a serious act of patent infringement. Such actions constitute a violation of the *Patent Law of the People's Republic of China* and other relevant laws and regulations. Our company will pursue full legal liability against such parties in accordance with the law, including—but not limited to—demanding the cessation of infringement, compensation for economic losses, and a public apology.

To substantiate our company's patent ownership and our unwavering resolve to defend our rights, we hereby publicly disclose the following supporting documentation:

1.Proof of patent application filing for the DR HUGO Rejuven S200 2ATA Soft-Shell Seated Hyperbaric Oxygen Chamber;

2. Official certification confirming the formal approval and issuance of the patent for the DR HUGO Rejuven S200;
Rejuven S200 Patent Grant and Recognition

3. Screenshots serving as evidence of successful infringement complaints filed by DR HUGO against copycat manufacturers on the Alibaba platform, demonstrating the platform's support for our claims.
Successful Patent Infringement Complaint

These materials conclusively validate our company's legitimate patent ownership regarding this product and underscore our firm commitment to combating infringement and upholding market order.

DR HUGO remains steadfast in its commitment to independent R&D and ethical business practices, dedicated to providing global clients with high-quality, highly safe hyperbaric oxygen chamber products and services. We maintain a zero-tolerance policy toward all forms of infringement and plagiarism appearing in the market. We will continuously intensify our efforts to protect our rights and closely monitor market developments; should any infringing activity be detected, we will immediately initiate legal proceedings to resolutely combat such acts to the very end, showing absolutely no leniency.

We hereby sincerely urge all our customers—both new and long-standing—to remain vigilant, carefully verify the authenticity of products, and strictly avoid purchasing counterfeit or plagiarized goods to safeguard your own rights and interests. Furthermore, we invite our valued customers to actively participate in our anti-infringement campaign; should you discover any suspected instances of plagiarism or infringement involving the DR HUGO Rejuven S200 product, please report them to us immediately. We pledge to treat all reported information with strict confidentiality and to appropriately acknowledge valid reports. Together with our customers, let us join hands to uphold a fair, just, and healthy market environment, thereby safeguarding the innovation and development of the hyperbaric oxygen chamber industry.

We extend our heartfelt gratitude to our loyal customers for your unwavering trust and support. Your feedback is invaluable and plays a crucial role in maintaining the reputation and integrity of our brand. Let us stand shoulder to shoulder to collectively reject counterfeit and substandard products, and to jointly defend true innovation.

Authentic quality is paramount. Core technology is essential. Above all, your safety and therapeutic efficacy remain our absolute top priority.